By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Foamix Pharmaceuticals, Ltd. 

2 Holzman Street
Weizmann-Science Park
Rehovot    76704  Israel
Phone: 972-8-9316233 Fax: n/a



Company News
Foamix Pharma (FOMX) Appoints David Domzalski As Chief Executive Officer 6/29/2017 8:56:35 AM
Foamix Pharma (FOMX) Announces Dosing Of First Patient In Phase III Rosacea Clinical Trials For FMX103 Minocycline Foam 1.5% 6/12/2017 6:42:34 AM
Foamix Pharma (FOMX) Reports First Quarter 2017 Financial Results And Provides Business Update 5/10/2017 10:56:13 AM
Foamix Pharma (FOMX) Announces Plans For Additional Phase III Trial For FMX101 In Moderate To Severe Acne 5/2/2017 6:17:56 AM
Foamix Pharma (FOMX) First Quarter Financial Results Conference Call & Webcast Scheduled For Tuesday, May 10 4/26/2017 10:51:13 AM
Foamix Pharma (FOMX) Craters As Acne Drug Flunks Phase III Test 3/27/2017 6:06:44 AM
Foamix Pharma (FOMX) Reports Year End 2016 Financial Results And Provides Business Update 2/22/2017 11:11:07 AM
Foamix Pharma (FOMX) To Release Fiscal Year 2016 Financial Results And Host Conference Call & Webcast On Wednesday, February 22 2/8/2017 10:27:38 AM
Foamix Pharma (FOMX) Announces Completion Of Patient Enrollment In Phase 3 Acne Trials For Minocycline Foam FMX101 11/28/2016 6:43:09 AM
Foamix Pharma (FOMX) Reports Third Quarter 2016 Financial Results and Provides Business Update 11/16/2016 8:56:52 AM